Bioleaders Corporation Cash Flow Conversion Efficiency

Latest as of June 2026: -0.039x

Bioleaders Corporation cash flow conversion efficiency. Based on the latest financial reports, Bioleaders Corporation (142760) has a cash flow conversion efficiency ratio of -0.039x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-932.70 Million ≈ $-632.07K USD) by net assets (₩24.19 Billion ≈ $16.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Bioleaders Corporation (2015–2025)

Cash flow conversion efficiency of Bioleaders Corporation from 2015 to 2025. This chart illustrates how Bioleaders Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Bioleaders Corporation stock price today for real-time trading data and today's change.

Bioleaders Corporation Cash Flow Conversion Ratio Explained

Bioleaders Corporation cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Bioleaders Corporation Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bioleaders Corporation ranked by their cash flow conversion efficiency. Also see Bioleaders Corporation stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Pensana Rare Earths Plc LSE:PRE	-0.065x
paragon GmbH & Co. KGaA F:PGN	0.013x
Haoxi Health Technology Limited Class A Ordinary Shares NASDAQ:HAO	-0.142x
CLS Holdings plc LSE:CLI	0.013x
Smiths News PLC LSE:SNWS	2.916x
iSpecimen Inc NASDAQ:ISPC	-0.397x
Human Xtensions Ltd TA:HUMX	-0.626x
POB AG NA O.N. XETRA:PO1	N/A

Annual Cash Flow Conversion Efficiency for Bioleaders Corporation (2015–2025)

The table below shows the annual cash flow conversion efficiency of Bioleaders Corporation from 2015 to 2025. Review 142760 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩30.57 Billion ≈ $20.71 Million	₩-5.97 Billion ≈ $-4.05 Million	-0.195x	-1352.26%
2024-12-31	₩37.31 Billion ≈ $25.28 Million	₩-501.75 Million ≈ $-340.03K	-0.013x	-107.80%
2023-12-31	₩35.79 Billion ≈ $24.26 Million	₩6.18 Billion ≈ $4.18 Million	0.173x	+118.16%
2022-12-31	₩21.69 Billion ≈ $14.70 Million	₩-20.60 Billion ≈ $-13.96 Million	-0.950x	-751.07%
2021-12-31	₩45.11 Billion ≈ $30.57 Million	₩-5.04 Billion ≈ $-3.41 Million	-0.112x	+37.04%
2020-12-31	₩30.60 Billion ≈ $20.74 Million	₩-5.43 Billion ≈ $-3.68 Million	-0.177x	-92.34%
2019-12-31	₩23.82 Billion ≈ $16.14 Million	₩-2.20 Billion ≈ $-1.49 Million	-0.092x	+75.30%
2018-12-31	₩23.50 Billion ≈ $15.92 Million	₩-8.77 Billion ≈ $-5.94 Million	-0.373x	-53.95%
2017-12-31	₩35.17 Billion ≈ $23.83 Million	₩-8.53 Billion ≈ $-5.78 Million	-0.242x	+45.00%
2016-12-31	₩17.46 Billion ≈ $11.83 Million	₩-7.70 Billion ≈ $-5.22 Million	-0.441x	+49.32%
2015-12-31	₩5.55 Billion ≈ $3.76 Million	₩-4.83 Billion ≈ $-3.27 Million	-0.870x	--

About Bioleaders Corporation

KQ:142760 Korea Biotechnology

Market Cap

$2.13 Million

₩3.14 Billion KRW

Market Cap Rank

#29955 Global

#2096 in Korea

Share Price

₩149.00

Change (1 day)

-15.82%

52-Week Range

₩149.00 - ₩1850.00

All Time High

₩24990.00